Read + Share
Bouhnik Y, Atreya R, Casey D, Gorecki M, et al. Cost-effectiveness Analysis of Subcutaneous Infliximab for Inflammatory Bowel
Diseases in Sequential Biologic Treatment. Inflamm Bowel Dis 2023;29:898-913.
PMID: 35942647
|
 |
|
Bouhnik Y, Atreya R, Casey D, Gorecki M, et al. Cost-effectiveness Analysis of Subcutaneous Infliximab for Inflammatory Bowel
Diseases in Sequential Biologic Treatment. Inflamm Bowel Dis 2023;29:898-913.
PMID: 35942647
|
|
|
|